Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Our company/
  3. Consumer products

Consumer products

Johnson & Johnson does not sell over-the-counter medicines or consumer products. The company is exclusively focused on developing and manufacturing innovative healthcare solutions for the world’s toughest diseases including novel medicines and medical technologies.

Consumer brands including Tylenol, Band-Aid Brand Adhesive Bandages and Johnson’s Baby are owned by Kenvue Inc., which has been an independent publicly traded company since August 2023. For a complete list of products, please see below and visit Kenvue for more information.

  • Listerine
  • Johnson’s Baby
  • Nicorette
  • Neutrogena
  • Aveeno
  • Tylenol
  • Motrin
  • Zyrtec
  • Rhinocort
  • Benadryl
  • Band-Aid Brand
  • Dr Ci:Labo
  • OGX
  • ORSL
  • Zarbee’s Naturals
  • Calpol
  • Carefree
  • Clean & Clear
  • Desitin
  • Johnson’s
  • Lubriderm
  • Rogaine
  • Versalie
  • Benylin
  • Daktarin
  • Imodium
  • Johnson’s Adult
  • Le Petit Marseillais
  • Maui Moisture
  • Microlax
  • Motilium
  • Neosporin
  • Neostrata
  • O.B.
  • Pepcid
  • Pulmicort
  • Regaine
  • Stayfree
  • Sudafed
  • Visine/Vispring/Visclear

More from Johnson & Johnson

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

Introducing the first and only daily disposable multifocal contact lens for people with astigmatism

A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.

How Johnson & Johnson is advancing the fight against Alzheimer’s disease

After decades of commitment to understanding this neurodegenerative disease, company scientists have developed innovative therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers. A cure is still elusive—but preventing the disease may be within reach.